Piper Sandler analyst Joseph Catanzaro initiates coverage on Context Therapeutics (NASDAQ:CNTX) with a Overweight rating and announces Price Target of $4.5.
- Company Dashboard
- Filings
- Patents
-
Article
Piper Sandler Initiates Coverage On Context Therapeutics with Overweight Rating, Announces Price Target of $4.5
Company Profile